Fund Holdings — Commodore Capital LP

Total Portfolio Value:
$1.60B
Total Bought:
$230.35M
Total Sold:
$96.25M
Net Transaction:
+$134.10M
Notable People:
Michael Jonathan Kramarz, Robert Egen Turrell Atkinson, Commodore Capital Gp Llc
Securities
▲▼
SharesValue
Q2 2024
▲▼
Q3 2024
▲▼
Change
▲▼
Q2 2024
▲▼
Q3 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Merus N V3,200,0003,350,000+150,000$189.34M$167.37M10.46%-$21.98M
Vera Therapeutics, Inc.CL A(VERA)2,475,0002,475,0000$89.55M$109.39M6.84%+$19.85M
Xenon Pharmaceuticals Inc.(XENE)2,754,2662,700,000-54,266$107.39M$106.30M6.64%-$1.09M
Vaxcyte, Inc.(PCVX)1,305,000920,000-385,000$98.54M$105.13M6.57%+$6.59M
Enliven Therapeutics Inc3,973,2454,100,000+126,755$92.85M$104.71M6.54%+$11.86M
Nuvalent Inc1,487,756940,000-547,756$112.86M$96.16M6.01%-$16.70M
Cogent Biosciences, Inc.(COGT)9,738,0007,539,930-2,198,070$82.09M$81.43M5.09%-$660.1K
Alkermes plcSHS(ALKS)1,375,0002,900,000+1,525,000$33.14M$81.17M5.07%+$48.03M
Soleno Therapeutics Inc1,425,0001,260,000-165,000$58.14M$63.62M3.98%+$5.48M
Spyre Therapeutics, Inc.(SYRE)1,988,0841,988,0840$46.74M$58.47M3.65%+$11.73M
Viridian Therapeutics, Inc.(VRDN)2,528,0322,550,124+22,092$32.89M$58.02M3.63%+$25.13M
Celldex Therapeutics, Inc.(CLDX)1,425,0001,618,937+193,937$52.74M$55.03M3.44%+$2.29M
Mind Medicine Mindmed Inc7,145,8888,000,000+854,112$51.52M$45.52M2.84%-$6.00M
Perspective Therapeutics, Inc.(CATX)4,657,3453,350,000-1,307,345$46.43M$44.72M2.79%-$1.71M
Nurix Therapeutics, Inc.(NRIX)01,650,000+1,650,000$0$37.08M2.32%+$37.08M
Pharvaris N V
COM
1,810,1751,911,433+101,258$34.03M$35.40M2.21%+$1.37M
Kura Oncology, Inc.(KURA)1,593,3501,800,000+206,650$32.81M$35.17M2.20%+$2.36M
Rhythm Pharmaceuticals, Inc.(RYTM)1,225,000650,000-575,000$50.30M$34.05M2.13%-$16.25M
Oruka Therapeutics, Inc.(ORKA)01,369,714+1,369,714$0$33.57M2.10%+$33.57M
Arvinas, Inc.(ARVN)1,884,3611,200,000-684,361$50.16M$29.56M1.85%-$20.61M
Celcuity Inc.(CELC)1,464,1051,522,332+58,227$23.98M$22.70M1.42%-$1.28M
Centessa Pharmaceuticals PlcADS01,350,000+1,350,000$0$21.59M1.35%+$21.59M
Nkarta, Inc.(NKTX)4,151,0344,662,073+511,039$24.53M$21.07M1.32%-$3.46M
ORIC Pharmaceuticals, Inc.(ORIC)2,000,0002,000,0000$14.14M$20.50M1.28%+$6.36M
C4 Therapeutics, Inc.(CCCC)3,410,3843,410,3840$15.76M$19.44M1.21%+$3.68M
Third Harmonic Bio Inc1,545,4261,360,569-184,857$20.09M$18.44M1.15%-$1.65M
Syndax Pharmaceuticals, Inc.(SNDX)825,000885,000+60,000$16.94M$17.04M1.06%+$99.0K
Apogee Therapeutics Inc290,000290,0000$11.41M$17.03M1.06%+$5.62M
ABIVAX Société AnonymeADS(ABVX)1,284,1101,284,1100$16.98M$14.79M0.92%-$2.18M
Instil Bio, Inc.(TIL)0150,929+150,929$0$10.16M0.63%+$10.16M
Neurogene Inc.(NGNE)200,000200,0000$7.28M$8.39M0.52%+$1.11M
Perceptive Cap Solutions CorCL A
CL A ORD SHS
750,000750,0000$7.54M$7.51M0.47%-$37.5K
Helix Acquisition Corp IiCL A500,000500,0000$5.11M$5.22M0.33%+$115.0K
Cabaletta Bio, Inc.(CABA)1,100,0001,100,0000$8.23M$5.19M0.32%-$3.04M
Vistagen Therapeutics, Inc.(VTGN)1,575,0001,575,0000$5.48M$4.74M0.30%-$740.3K
Avalo Therapeutics, Inc.(AVTX)40,000483,000+443,000$498.8K$4.59M0.29%+$4.09M
Arca Biopharma Inc414,3250-414,325$1.59M$0—-$1.59M
Autolus Therapeutics plcADS(AUTL)1,178,7230-1,178,723$4.10M$0—-$4.10M
Immunovant, Inc.(IMVT)750,9900-750,990$19.83M$0—-$19.83M
Page 1 of 1
Commodore Capital LP — 13F Holdings — Q3 2024 | TickerTrail